Correlation Between Quoin Pharmaceuticals and Carmell Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Carmell Therapeutics, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Carmell Therapeutics.

Diversification Opportunities for Quoin Pharmaceuticals and Carmell Therapeutics

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Quoin and Carmell is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Carmell Therapeutics go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and Carmell Therapeutics

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Carmell Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Quoin Pharmaceuticals Ltd is 2.58 times less risky than Carmell Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Carmell Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  15.00  in Carmell Therapeutics on September 2, 2024 and sell it today you would lose (9.00) from holding Carmell Therapeutics or give up 60.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy31.45%
ValuesDaily Returns

Quoin Pharmaceuticals Ltd  vs.  Carmell Therapeutics

 Performance 
       Timeline  
Quoin Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Quoin Pharmaceuticals Ltd are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quoin Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Carmell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days Carmell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Carmell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Quoin Pharmaceuticals and Carmell Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quoin Pharmaceuticals and Carmell Therapeutics

The main advantage of trading using opposite Quoin Pharmaceuticals and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.
The idea behind Quoin Pharmaceuticals Ltd and Carmell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals